Catalyst Wire Dossier Catalyst Wire Dossier

RETROVIR

Zidovudine · ViiV Healthcare Company
Drug timelines are a Plus or Pro feature.

60 regulatory and trial events tracked for RETROVIR, covering 2006-05-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma [Phase 2]

See pricing